73
Views
4
CrossRef citations to date
0
Altmetric
Review

How to manage difficult Crohn’s disease: optimum delivery of anti-TNFs

, &
Pages 407-415 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nazila Assasi, Gord Blackhouse, Feng Xie, John K Marshall, E Jan Irvine, Kathryn Gaebel, Diana Robertson, Kaitryn Campbell, Rob Hopkins & Ron Goeree. (2010) Patient outcomes after anti TNF-α drugs for Crohn’s disease. Expert Review of Pharmacoeconomics & Outcomes Research 10:2, pages 163-175.
Read now

Articles from other publishers (3)

Montserrat Corbera-Hincapie & Genie L. Beasley. (2018) A Challenging Treatment Decision for a Rare Association: Case Report of Familial Turcot Syndrome With Fistulizing Crohn’s Disease. Frontiers in Pediatrics 6.
Crossref
James C. Lee, Marion Espéli, Carl A. Anderson, Michelle A. Linterman, Joanna M. Pocock, Naomi J. Williams, Rebecca Roberts, Sebastien Viatte, Bo Fu, Norbert Peshu, Tran Tinh Hien, Nguyen Hoan Phu, Emma Wesley, Cathryn Edwards, Tariq Ahmad, John C. Mansfield, Richard Gearry, Sarah Dunstan, Thomas N. Williams, Anne Barton, Carola G. Vinuesa, Miles Parkes, Paul A. Lyons, Kenneth G.C. Smith, Anne Phillips, Craig Mowat, Hazel Drummond, Nick Kennedy, Charlie W. Lees, Jack Satsangi, Kirstin Taylor, Natalie J. Prescott, Christopher G. Mathew, Peter Simpson, Alison Simmons, Mohammed Khan, William G. Newman, Christopher Hawkey, Ailsa Hart, David C. Wilson, Paul Henderson & Jeffrey C. Barrett. (2013) Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway. Cell 155:1, pages 57-69.
Crossref
Stefan Schreiber. (2011) Certolizumab pegol for the treatment of Crohn’s disease. Therapeutic Advances in Gastroenterology 4:6, pages 375-389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.